Pulmonary nodules
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Male and female aged 18 to 75 years old; (2) pulmonary nodules were diagnosed by thoracic CT (diameter = 1cm, solid nodules or ground glass nodules), and to be undergoing thoracoscopic pulmonary wedge resection or segmentectomy or lobectomy; (3) thoracic CT examination showed no significant enlargement of the hilar or mediastinal lymph nodes; (4) voluntarily participate and sign informed consent form, and can complete the entire trial.
Exclusion criteria
Exclusion criteria: (1) The patients who were not suitable for puncture location before operation, such as pleural effusion, severe damage to the lung tissue, etc.; (2) systemic factors, sepsis, pulmonary infection, any type of serious infection diseases within one month; (3) serious heart, brain, lung, liver, kidney disease, severe hypertension patients; (4) severe coagulation dysfunction; (5) with distant metastasis; (6) patients participated in clinical trials of other drugs or medical devices within 30 days prior to screening; (7) other cases of this clinical trial are not considered appropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of Localization success; | — |
Secondary
| Measure | Time frame |
|---|---|
| complication; | — |
Countries
China
Contacts
SHANGHAI CHEST HOSPITAL